OLVIG
NUVB icon

Oliver Lagore Vanvalin Investment Group’s Nuvation Bio NUVB Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,100
Closed -$4.81K – 718
2024
Q3 		$4.81K Buy
2,100
+1,600
+320% +$4.88K ﹤0.01% 510
2024
Q2 		$1.46K Buy
+500
New +$1.53K ﹤0.01% 625

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's NUVB Position: Q4 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Nuvation Bio (NUVB) in Q4 2024, closing a stake of 2,100 shares — an estimated $4.81K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in NUVB in Q2 2024 and held it in 2 quarters. The position peaked at $4.81K in Q3 2024. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Nuvation Bio position as of Q4 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 2,100 Nuvation Bio shares in Q4 2024, an estimated $4.81K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Nuvation Bio in Q2 2024 and held it in 2 quarters.
  • Oliver Lagore Vanvalin Investment Group's Nuvation Bio position peaked at $4.81K in Q3 2024.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q4 2024, filed 1 Apr 2025.